Prof A Suhrbier is the Group Leader of the Inflammation Biology Group at the Queensland Institute of Medical Research. The group focuses at the applied end of inflammation research and development and will be involved in the identification and development of new interventions and diagnostics for inflammatory diseases and cancer, often in collaboration with the biotech industry.
This research draws together my expertise in medicinal chemistry, biochemistry, pharmacology and virology to design and develop new compounds that we can use to interrogate and regulate human and viral proteins that cause disease. Protein, cell and animal studies relevant to major 21st century health burdens (such as inflammatory, infectious and metabolic diseases, cancer, pain and viral infections) will provide important new information on mechanisms of disease development and drug action.